be_ixf;ym_202605 d_08; ct_50

Latest Insights on VIR

Things are getting spooky in the social media market, and it could have grave consequences for your portfolio! Facebook’s Thriller; Apple Bobbing; Ghouls and Googles October 30, 2020 by Joseph Hargett Great Stuff Friday Four Play: The “FAANG Thriller Bonanza” Edition It’s close to midnight, and social media’s lurking in the dark. Under your screen light, you see a sight that almost stops your heart… Facebook Inc. (Nasdaq: ) saw daily active users (DAU) drop by two million during the third quarter. Elsewhere, Twitter Inc. (NYSE: ) also […]
Buying, selling, laughing? Anything goes in this market. Hear how Great Stuff readers stay sane amid the insanity. Have Feedback, Will Travel: Economy, Cruises and Puts October 29, 2020 by Joseph Hargett Great Stuff The “All of the Above” Economy ‘Sup, Great Ones? Welcome to Reader Feedback day! Today, as always, is about you. Your stock market questions. Your investment hopes. Your Wall Street rants. Your deepest options desires. Um … desires, Mr. Great Stuff? Don’t worry, I won’t pull any of that Tom Ellis Lucifer mojo on you. […]
1 Stock That Stands Up to the Stormy Market October 29, 2020 by Lina Lee 2020 Financial Crisis, American Investor Today, Investing, Technology (3-minute read) There’s volatility around the world today … but we are still finding ways to help our retirements. The “Subscription of Everything” stocks keep growing even in this down market. Read more…
You know what they say about baseball card collecting in the ‘80s and the stock market. Well, maybe you don’t, but it ain’t pretty… Winter Is Coming; Forests of Azure, Cloudless Solar Skies October 28, 2020 by Joseph Hargett Great Stuff Future in the Cards Sooo … how about those Dodgers? I don’t follow baseball — I got burned on baseball cards back in the late ‘80s and early ‘90s, and it’s been downhill ever since. Anyone else have a massive box of three-decades-old baseball cards that are worth absolutely nothing right now? Oddly enough, there’s […]
Invest in Biotech With 1 Buy October 27, 2020 by Chad Shoop 2020 Financial Crisis, American Investor Today (9-minute video) In the war against COVID-19, American biotech companies are paving the path. The latest success is Gilead’s remdesivir winning FDA approval. Will this be the start of a new uptrend for the stock?

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

Share This